1Feaerherm A J, BOrset M, Seidel C, et al. Elevated levels of osteo- protegerin (OPG) and hepatocyte growth factor (HGF) in rheuma- toid arthritis. Stand J Rheumatol, 2001,30:229 -234.
3Haynes DR, Barg E, Crottil TN, et al. Osteoprotegerin expression in synovial tissue frompatients with rheumatoid arthritis, spondyloax- thropathies and osteoarthritis and normal controls. Rheumatology, 2003,42 : 123-134.
4Brendan BF, David HE, Kenneth WR, et al. Recent Advances in Bone Biology Provide Insight into the Pathogenesis of Bone Disea- ses, Nature, 1999,79 (2) ,83-94.
5Gravallese EM, Galson D, Goldring SR, et al. The role of TNF-re- ceptor family members and other TRAFdependent receptors in bone resorption. Arthritis Res, 2001,3:6-12.
6CoUin-Osdoby P, Rothe L, Anderson F, et al. Receptor activator of NF-Kappa B and osteopretegerin expression by human microvascular endothelial cells, inflammatory cytokines, and role in human oste- oclastogenesis. J Biol Chem, 2001,276:20659-72.
7Haynes DR, Crotti TN, Capone M, et al. Osteoprotegerin and re- ceptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology, 2001,40:623-30.
8Susanne Brosch, Redlich K, Pietschmann P. Pathogenese der Os- teoporose bei chronischer polyarthritis. Acta Med. Austricaca,2003, 30 : 1-5.
9Leonard H. Sigal, MD. Molecular Biology and Immunology for Cli- nicians 23 Autoimmunity and the Superfamilies of Tumor Necrosis Factor and Tumor Necrosis Factor Receptor. J Clin Rheumatology, 2003,9 : 119-125.
10Fukuda T, Ichimura E, Shinozaki T et al. Coexpression of HGF and e-Met/HGF receptor in human bone and soft tissue tumors. Pathology International, 1998,48:757-762.
